Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine combined with hydromorphone for postoperative PCIA after gynecologic laparoscopic surgery
ChiCTR1800017188Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine and hydromorphone in postoperative pain (5 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Visual analogue scale pain score. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
nalbuphinehydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800017188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017188.